CMS

Good News for COVID-19 Testing Companies: Medicare Nearly Doubles Reimbursement
Motley Fool
Fri, 04/17/20 - 10:53 am
CMS
Medicare
diagnostics
COVID-19
reimbursement
The Latest CMS Outlook for Drug Spending—And How COVID-19 Will Change It
Drug Channels
Tue, 04/7/20 - 10:12 am
drug spending
CMS
COVID-19
CMS delays clinical lab fee schedule data reporting, cuts capped at 15% for 2021
Medtech Dive
Sun, 01/5/20 - 07:13 pm
CMS
devices
diagnostics
clinical laboratory fees
Latest CMS Data: Drug Spending is Not Skyrocketing; Hospitals and Physicians Dominate Healthcare Costs
Drug Channels
Tue, 12/10/19 - 10:29 am
CMS
drug spending
hospitals
CMS proposes lifting restrictions on NGS cancer testing
Biopharma Dive
Thu, 10/31/19 - 10:39 am
CMS
next generation sequencing
diagnostics
oncology
cancer
Medicare
Preferred Pharmacy Networks Rebound in 2020 Medicare Part D Plans: Details on WellCare, CVS Health, Humana, Cigna, and More
Drug Channels
Tue, 10/22/19 - 11:00 pm
CMS
Medicare
Medicare Part D
preferred pharmacy networks
CMS to cover CAR-T therapy nationwide
Beckers Hospital Review
Thu, 08/8/19 - 10:53 am
Medicare
CMS
CAR-T
CMS prescribes payment fix to resuscitate US antibiotic industry
Endpoints
Mon, 08/5/19 - 11:11 am
CMS
antibiotics
drug development
Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS
Fierce Pharma
Mon, 07/1/19 - 12:06 pm
CMS
hopsitals
physicians
physician payments
CMS approves Louisiana's 'Netflix model' with Gilead for hepatitis C drugs
Biopharma Dive
Wed, 06/26/19 - 11:49 pm
hepatitis C
Medicaid
Netflix model
Louisiana
Gilead Sciences
CMS
Federal Court Punts Regarding Remedy Related to CMS’ Invalidated Rule Concerning Medicare Hospital Outpatient Payment Rates for 340B Drugs
FDA Law Blog
Fri, 05/17/19 - 07:16 pm
FDA
CMS
Medicare
340B
CMS reopens coverage determination on next-gen sequencing for cancer patients
Medtech Dive
Tue, 04/30/19 - 09:43 pm
CMS
Medicare
next generation sequencing
cancer
How a Medicare Rule Change Could Bring CAR-T Stocks Back to Life
Motley Fool
Sat, 04/27/19 - 10:47 am
Gilead Sciences
Novartis
CMS
Medicare
CAR-T
Medicare proposes raising CAR-T pay, but reimbursement solution years away
Biopharma Dive
Wed, 04/24/19 - 03:58 pm
CMS
CAR-T
Medicare
reimbursement
CMS demo could pave the path to eliminating Part D rebates
BioCentury
Mon, 04/8/19 - 11:18 pm
CMS
drug pricing
Medicare Part D
drug rebates
Electronic Health Records: A Promising New Way To Fight the Opioid Epidemic
Forbes
Fri, 03/15/19 - 08:37 pm
opioids
opioid crisis
EHRs
EMRs
CMS
Drug spending could rise 6.1 percent annually by 2020, federal projections show
Stat
Wed, 02/20/19 - 08:01 pm
drug spending
CMS
Medicare would cover CAR-T cell therapies under new CMS proposal
Marketwatch
Fri, 02/15/19 - 12:22 pm
Medicare
CAR-T
cell therapy
CMS
Novartis
Kymriah
Gilead Sciences
Yescarta
Governor moves to boost California's drug price bargaining power
BioCentury
Tue, 01/8/19 - 07:11 pm
drug pricing
CMS
Medicaid
California
CMS rule cuts reimbursement for new Part B drugs
BioCentury
Fri, 11/2/18 - 08:02 pm
Medicare Part B
CMS
reimbursement
physician-administered drugs

Pages